Ghislaine Gilleron
Plus aucun poste en cours
Historique de carrière de Ghislaine Gilleron
Anciens postes connus de Ghislaine Gilleron
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MiddleNext
 MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Directeur/Membre du Conseil | 01/06/2011 | - |
| ELSALYS BIOTECH | Fondateur | 01/01/2013 | - |
| TRANSGENE | Conseiller Juridique Général | 01/01/1985 | 01/01/1985 |
| Secrétaire Général | 01/01/1985 | - |
Formation de Ghislaine Gilleron
| Institut d'Études Politiques d'Aix-en-Provence | Undergraduate Degree |
Statistiques
Internationale
| France | 5 |
Opérationnelle
| General Counsel | 1 |
| Corporate Secretary | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Entreprise privées | 2 |
|---|---|
MiddleNext
MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Commercial Services |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Bourse
- Insiders
- Ghislaine Gilleron
- Expérience
